Rituximab May Be Best Choice After Anti-TNF Fail in RA Medscape March 24, 2012 — Patients whose rheumatoid arthritis (RA) is inadequately controlled with a tumor necrosis factor (TNF) inhibitor might be well advised to switch to rituximab (RTX), rather than to a different TNF inhibitor, according to data from the ... |
